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Epidermolysis bullosa (EB) is a group of inherited blistering skin diseases that vary widely in their pathogenesis and severity. There
are three main categories of EB: simplex, junctional, and dystrophic. This classification is based on the level of tissue separation
within the basement membrane zone and this is attributed to abnormalities of individual or several anchoring proteins that form
the interlocking network spanning from the epidermis to the dermis underneath. Dystrophic EB results from mutations in COL7A1
gene coding for type VII collagen leading to blister formation within the dermis. Diagnosis ultimately depends on the patient’s
specific genetic mutation, but initial diagnosis can be made from careful examination and history taking. We present a pregnant
patient known to have autosomal dominant dystrophic EB and discuss the obstetrical and neonatal outcome. The paper also reviews
the current English literature on this rare skin disorder.

1. Background
Epidermolysis bullosa (EB) is a group of inherited blistering
skin diseases that vary widely in their pathogenesis and
severity [1]. EB is divided into three main categories (simplex,
junctional, and dystrophic) based on the level of tissue separation within the basement membrane zone [1, 2] and this is
attributed to abnormalities of individual or several anchoring
proteins that form the interlocking network spanning from
the epidermis to the dermis underneath [3] (Table 1). EB
simplex is caused by mutations in keratin 5, keratin 14, or
plectin genes which result in blister formation within the
basal keratinocytes [2]. The junctional forms of EB are all
inherited in a recessive pattern and involve mutations in
laminin 332, BPAG2, 𝛼6 integrin, or 𝛽4 integrin genes and
result in skin separation at the lamina lucida [2]. Dystrophic
EB results from mutations in COL7A1 gene coding for type
VII collagen leading to blister formation within the dermis
[2, 3]. Diagnosis ultimately depends on the patient’s specific
genetic mutation, but initial diagnosis can be made from careful examination and history taking [2]. We present a pregnant
patient known to have autosomal dominant dystrophic EB

(ADDEB) and discuss the obstetrical and neonatal outcome
followed by a review of the current literature on this rare
entity.

2. Case Illustration
Our patient is a 19-year-old Caucasian female, G5P0040,
who had routine prenatal care at our clinic. Her pregnancy
had been complicated by a history of a seizure and bipolar
disorders and personal history of ADDEB with documented
COL7A1 gene mutation. The patient reported a family history
of the disease in her maternal great aunt who was deceased;
however, accurate information pertaining to the manifestations of her skin disorder could not be confirmed. The patient
herself was born through a vaginal route and had been told
that she had blistering and bullae formation that covered the
vast majority of her body surface shortly after she was born.
Throughout her early childhood years, she had recurrent
skin blistering, particularly in her hands and fingers. By the
age of three, she underwent surgical release of interdigit
webbing between the fingers of both hands. Her disease

Dystrophic EB (DEB)

Autosomal recessive

Junctional EB (JEB)

Autosomal recessive

Autosomal dominant

Autosomal dominant

Inheritance

EB simplex (EBS)

Major type

Recessive DEB nonHallopeau-Siemens

Recessive DEB
HallopeauSiemens (HS)

Type VII collagen

Α6𝛽4 integrin

JEB pyloric atresia

Dominant DEB

Laminin 5, type XVII collagen

Laminin 5

JEB Herlitz

JEB non-Herlitz

Plectin

K5, K14

EBS muscular
dystrophy

EBS Dowling-Meara

EBS Koebner

EBS Weber-Cocayne

Protein/gene involved

Sublamina densa

Intraepidermal and/or intralamina densa

Intralamina densa

Intraepidermal

Level of cleavage

Table 1: Classification of common inherited epidermolysis bullosa (EB) phenotypes.
Major subtype

(i) Present at birth
(ii) Scarring being less severe than in HS type
(iii) Extracutaneous manifestations that may be
present

(i) Present at birth
(ii) Extensive scarring
(iii) Extracutaneous involvement
(iv) Increasing risk of SCC
(v) 8% mortality risk by the age of 15

(i) Pyloric atresia
(ii) Wide variety in severity of blistering
(iii) Often fatal at early age
(i) Onset at birth or in early childhood
(ii) Uncommon extracutaneous manifestations
(iii) Abnormal nails and atrophic scarring

(i) Present at birth
(ii) Milder form of JEB with minimal extracutaneous
involvement
(iii) High infant mortality (40% in first year of life
and rising to 61.8% by the age of 15)

(i) Onset in late childhood
(ii) Generalized blistering and muscle weakness
(i) Present at birth
(ii) Intractable blistering and erosions
(iii) High infant mortality (40% in first year of life
and rising to 61.8% by the age of 15)

(i) Onset in infancy
(ii) Herpetiform grouping of blisters
(iii) Symptoms improving with age
(iv) Infant mortality rate of 2.8% in first year of life

(i) Present at birth
(ii) Worse blistering on extremities

Manifestations
(i) Onset in late childhood or early adulthood
(ii) Blisters on palms and soles
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activity diminished with advancing age thereafter. Her gingiva, buccal mucosa, teeth, and hands were normal at the time
of her current pregnancy. Occasional blistering occurred with
mechanical stress; however, perineal and vaginal epithelium
sustained no blistering with normal vaginal intercourse. She
was otherwise healthy. Her partner had no known family or
personal history of EB (Figure 1—Pedigree). Throughout her
prenatal care, the patient adamantly expressed her desire to
undergo an elective cesarean delivery. Her desire stemmed
from the fear that her infant would suffer from generalized
body skin blistering if delivered vaginally as she had when
she was born. She had an uneventful prenatal course. Despite
having no absolute indications for a cesarean route of delivery
and after proper counseling, she received intrathecal spinal
anesthesia and underwent an elective low transverse cesarean
delivery at 39 weeks of gestation. She delivered a male infant
weighing 3000 grams with Apgar scores of 8 and 9. The
immediate postoperative period was unremarkable for both
neonate and mother. The patient sustained no blisters on
or around her skin incision throughout her hospital stay
and remained to be blister-free on her 2-week postoperative
check-up. Her infant however exhibited signs of skin erythema and blistering over its back (0.5 cm), inguinal (1 cm),
and right buttock areas (0.5 cm) by day 1 of life. Within 3
days, diffuse erythematous and bullous lesions progressively
appeared and covered the neonate’s chin, forearms, face
(Figure 2), thumbs, fingers, left buttocks, remaining area
of the back, and both legs covering approximately 30%
of its total body surface. There was evidence of blistering
and ruptured bullae but no secondary bacterial infections.
Guidelines for skin care of neonates with suspected EB
were implemented. These include using bland emollients,
avoiding restrictive clothing and overheating, minimizing
skin trauma, and rupturing of blisters using sterile needles, with topical antibiotics when needed. The differential
diagnosis in this particular case was that of EB simplex
versus ADDEB. A skin biopsy from the infant’s back was
performed and immunofluorescence mapping confirmed the
suspected ADDEB in this neonate with low expression of
type VII collagen in the basement membrane (Figure 3).
Both patient and neonate were discharged on hospital day
4 in a stable condition. She elected to bottle feed to avoid
possible nipple blistering. As of this writing, maternal health
has been stable and unchanged. Except for occasional blister
and bullae formation, the neonate had what seems to be a
mild phenotype of ADDEB with progressive resolution of
the skin lesions over the course of 4 weeks after birth. By
the third month of life, the newborn had been attaining
all developmental milestones and had minimal blisters and
bullae with normal fingers and nail beds.

3. Dystrophic Epidermolysis Bullosa
Dystrophic epidermolysis bullosa (DEB) is divided into three
autosomal subtypes: autosomal dominant DEB (ADDEB),
recessive DEB (RDEB), and severe generalized recessive DEB
(SGRDEB), previously Hallopeau-Siemens subtype (Table 1).
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Figure 1: Pedigree showing the affected mother (white asterisk),
unaffected partner (black asterisk), and affected infant (white
arrow).

∗

Figure 2: The newborn with widespread facial (asterisk) and
forearm skin blistering (arrow).

Clinical presentation of DEB in neonates is somewhat variable with more severe blistering generally occurring in the
recessive rather than the dominant subtypes.
The most common form of DEB is the autosomal dominant subtype, which is also the mildest form. Patients with
ADDEB may present along a clinical spectrum ranging from
localized blistering at sites of frequent trauma to generalized
blisters that resolve with atrophic scarring. Generalized
blistering may be seen at birth with alopecia, atrophic
scarring, and dystrophic nails developing later. The majority
of ADDEB cases do not present until early childhood and the
course of the disease is relatively mild. One of the localized
forms of ADDEB, the pretibial type, typically presents in
early childhood with blistering on the pretibial skin and
dorsum of the foot. Nail beds tend to be abnormal, but
extracutaneous involvement is absent. Generalized forms of
ADDEB, previously known as Pasini and Cockayne-Touraine
variants, present at birth and are associated with milia
and severely deformed or absent nail beds. Extracutaneous
symptoms are reported in a minority of patients [3]. Mortality
secondary to ADDEB has not been reported.
RDEB presents with blistering and erosions at birth with
positive Nikolsky’s sign (extension of blistering or sloughing
of epidermis with application of gentle pressure to lesion
or perilesional skin) and is associated with scarring, milia,
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(a)

(b)

Figure 3: Immunofluorescence staining of the dermal-epidermal junction with antibodies to type VII collagen showing a control normal
expression (a) and the minimal expression (b) of type VII collagen.

and dystrophic nail beds. Atrophic scarring with alopecia,
anemia, and growth retardation are common. Later in life,
blistering occurs almost exclusively in folds of skin and
patients frequently have mucosal manifestations of disease
such as intraoral blistering and scarring that results in
microstomia and ankyloglossia. Involvement of the esophagus can also occur. RDEB centripetalis is a subtype that also
presents with blistering in infancy, but the blisters progress
in a centripetal pattern and no intraoral or extracutaneous
lesions are seen [3]. Patients with SGRDEB present with
widespread blistering in infancy that involves the oral cavity
and esophagus. Extensively painful and pruritic blistering
results in contractures and pseudosyndactyly resulting in
severe deformities. Extracutaneous manifestations are common with oral, ocular, anal, gastrointestinal, and genital
mucous membrane involvement and can result in severe erosions and scarring resulting in microstomia, ankyloglossia,
esophageal strictures, malnutrition, and constipation [3, 4].
Abnormal enamel and cementum lead to lifelong dental
complications. The cumulative risk of death in children with
RDEB is 8% by the age of 15 [5]. Sepsis, failure to thrive,
and respiratory failure are the major causes of death [5].
All patients with DEB are at an increased risk of developing
squamous cell carcinoma with a cumulative risk of 90% by
the age of 55 [3, 4, 6].

4. DEB in Pregnancy
Management of pregnancy and delivery in patients with DEB
can be challenging due to the limited literature available and
lack of established guidelines for best practice [7]. A multidisciplinary approach involving obstetrics, anesthesiology, and
dermatology is essential [6]. Many women are apprehensive
about vaginal delivery because of the possibility of genital
blistering and scarring and neonatal blistering, but caesarean
section is not a straight-forward alternative [6, 7]. Blistering
over the spine may interfere with spinal anesthesia, and
trauma from intubation may result in life-threatening upper
airway complications and serious postoperative complications [6–8]. The current pregnancy-related DEB literature

is limited and primarily focuses on the recessive forms of
DEB since those patients tend to be more severely affected
and more likely to suffer from complications than individuals
with ADDEB [6–10].
A literature review of DEB in pregnancy yielded several
case reports and case series. The majority of reported patients
have undergone vaginal deliveries, which some authors
believe should be the first choice [10] despite a theoretical
risk of vaginal mucosal blistering [6]. Of the five reports
on pregnancy and delivery in patients with recessive DEB,
eight out of ten women had vaginal deliveries without
genital ulceration, vaginal scarring, or stenosis [6–10]. One
of the eight women had excessive bleeding during her first
pregnancy, but the remaining were uncomplicated [6–10].
Five of these women had more than one vaginal delivery,
and several were able to breastfeed without nipple blistering
or ulceration [6, 7]. One of the patients had a caesarean
section performed due to genital ulceration, fetal growth
restriction, and premature rupture of membranes with the
onset of preterm labor at 36 weeks of gestation. The caesarean
section was associated with blistering around the incision site,
but no infection or wound separation was noted [8]. Another
patient elected to have a caesarean section due to a strong
fear of vaginal delivery, and she suffered no complications
from the surgery [6]. A possible correlation between DEB
and intrauterine growth restriction has been suggested as well
[11]. In each of these reported pregnancies, a healthy neonate
was delivered without evidence of skin disease [6–10]. In all
deliveries, whether vaginal or caesarean delivery is attempted,
special care is taken to prevent any unnecessary trauma to the
skin [6].

5. Discussion
Our patient had a known history of ADDEB with documented COL7A1 gene mutation and delivered a neonate
with suspected ADDEB that was proven on pathological
evaluation. The patient’s family history was only significant
for a great maternal aunt with possible epidermolysis bullosa
but no definitive information could be obtained to discern the
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subtype. In Figure 1, the patient was the only individual with
the ADDEB phenotype and this was passed on to her infant.
Genetic testing for COL7A1 mutation was negative in the
patient’s partner (biological father of the affected neonate).
This suggests that the patient may have acquired a de novo
mutation in COL7A1 as she tested positive for the mutation;
however, the exact type of mutation was not identified.
A multidisciplinary approach that involved anesthesiology,
pediatrics, obstetrics, and dermatology was used in the management of this particular pregnancy. Previously published
guidelines in the management of DEB in pregnancy were
utilized to improve maternal and neonatal outcomes in
our patient [4, 6, 12]. Given the fact that our patient had
extensive bullae and blistering of her skin when she was born
vaginally and the fact that her infant sustained similar lesions
after being delivered by cesarean section, it seems prudent
that pregnant individuals with known ADDEB may deliver
vaginally and/or via cesarean section with the thought that
the neonate’s skin is very likely to blister. We are unable to
verify which route of delivery is associated with less blistering
in ADDEB as our information is limited by the retrospective
nature of the mother’s symptoms upon birth and the inability
to verify the percent body area involved when she was born
vaginally. Nonetheless for counseling purposes individuals
with ADDEB should be informed about the inevitable risk
of a neonate’s risk of blister and bullae formation with either
route of delivery. Unless absolutely necessary, we recommend
that operative vaginal delivery be avoided in such situations
in order to minimize mechanical trauma to the fetal head
prior to delivery. In light of the available literature [6–10]
and as in our patient, the vaginal mucosa of patients with
EB seems to withstand regular sexual intercourse and full
term labor and delivery without consequential ulceration
or exacerbation of underlying disease. Cesarean section can
be safely performed in patients with EB [6, 8] and may
be considered for obstetrical indications [7], but neonatal
skin blistering is likely to occur particularly in the ADDEB
subtype as the mutation confers a definite risk on the
neonate. In light of the potential complications of surgery, our
patient case, the low number of reported cases of ADDEB
in pregnancy, and the favorable neonatal outcomes, we do
believe that a vaginal route for delivery is the safest option
for both mother and infant in ADDEB.

6. Conclusions
ADDEB in pregnancy is a rare entity. Guidelines for its
management in pregnancy are scarce at best as most of
the DEB literature revolves around its recessive forms. The
medical literature however provides us with a gamut of
strategies to minimize blister and bullae formation in both
pregnant individuals and neonates alike with DEB. In this
case report, we reflect upon the challenges that ADDEB poses
on any pregnancy. Whether a vaginal or cesarean route is
chosen, neonates of mothers with COL7A1 mutation and
ADDEB seem to be at a definite risk of sustaining skin blisters
and bullae after delivery. Given no obstetrical indications for
a cesarean delivery, the vaginal route for delivery is most
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likely the safest option. Accordingly, proper counseling of
the risks and benefits to maternal and neonatal health is
the key in individualizing management plans in pregnancies
complicated by ADDEB.
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